RxDoctor Payments Data

Christopher Coogan, MD

Urology · Chicago, ILNPI 1568412716

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $894 of the $1,316 with a category attached, or 68.0%. 12 manufacturers reported payments, led by Olympus America Inc. at 32.0% of the total. Reporting peaked in 2023 at $583 and has fallen 77.4% since, to $132 in 2025. That places this record below the midpoint for urology clinicians in IL, where the typical reported total is $2,058.

$1,316in general payments, 2019–2025

Across 17 payments — averaging $77.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus America Inc.$422
  • Boston Scientific$329
  • Medtronic$224
  • Dendreon Pharmaceuticals LLC$74
  • Coloplast$70
  • Procept Biorobotics Corporation$43
  • plus $156 from 6 others

What the payments were for

  • Food & beverage$89468%
  • Other$42232%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Olympus America Inc.1$422
Boston Scientific3$329
Medtronic2$224
Dendreon Pharmaceuticals LLC1$74
Coloplast1$70
Procept Biorobotics Corporation1$43
Novo Nordisk2$36
Merck1$31
Rochester Medical Corporation2$28
180 Medical, Inc.1$23
Travere Therapeutics, Inc.1$22
Eisai Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,316 in reported general payments places this provider in the 40th percentile of 550 urology providers in Illinois.

See all urology providers in Illinois →

Medicare billing

Part B allowed, 2024
$175,098
Medicare patients
867
Services billed
1,975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl829$18,801
MyrbetriqMirabegron13$13,418
Finasteride520$8,261
GemtesaVibegron12$6,816
Alfuzosin Hcl ErAlfuzosin Hcl133$3,124
Trospium Chloride ErTrospium Chloride11$2,136
Dutasteride22$530
Doxazosin Mesylate19$376
Oxybutynin Chloride ErOxybutynin Chloride17$358
Terazosin Hcl22$337
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav48$328
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$233
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim65$220
Cefdinir11$189
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$177

Paid to pharmacies, not to this prescriber.

Other urology in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →